91. O3-7-4Risk Factor Analyses of Severe Cicatricial Stricture after Chemoradiotherapy for Stage II/III (T3) Esophageal Carcinoma. (3rd November 2017) Authors: Kitamura (Tsushita), Natsuko; Honma, Yoshitaka; Nagashima, Kengo; Shoji, Hirokazu; Takashima, Atsuo; Iwasa, Satoru; Kato, Ken; Hamaguchi, Tetsuya; Itami, Jun; Boku, Narikazu Journal: Annals of oncology Issue: Volume 28(2017)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
92. Outcomes Associated With Cardiogenic Shock in Takotsubo Syndrome: Results From the International Takotsubo Registry. Issue 3 (15th January 2019) Authors: Di Vece, Davide; Citro, Rodolfo; Cammann, Victoria L.; Kato, Ken; Gili, Sebastiano; Szawan, Konrad A.; Micek, Jozef; Jurisic, Stjepan; Ding, Katharina J.; Bacchi, Beatrice; Schwyzer, Moritz; Candreva, Alessandro; Bossone, Eduardo; D'Ascenzo, Fabrizio; Sarcon, Annahita; Franke, Jennifer; Napp, L. ... Journal: Circulation Issue: Volume 139:Issue 3(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
93. Pembrolizumab for the treatment of esophageal cancer. (2nd October 2020) Authors: Yamamoto, Shun; Kato, Ken Journal: Expert opinion on biological therapy Issue: Volume 20:Number 10(2020) Page Start: 1143 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
94. Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study. Issue 10302 (28th August 2021) Authors: Sun, Jong-Mu; Shen, Lin; Shah, Manish A; Enzinger, Peter; Adenis, Antoine; Doi, Toshihiko; Kojima, Takashi; Metges, Jean-Philippe; Li, Zhigang; Kim, Sung-Bae; Cho, Byoung Chul; Mansoor, Wasat; Li, Shau-Hsuan; Sunpaweravong, Patrapim; Maqueda, Maria Alsina; Goekkurt, Eray; Hara, Hiroki; Antunes, L... Journal: Lancet Issue: Volume 398:Issue 10302(2021) Page Start: 759 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
95. Pembrolizumab: first anti-PD-1/L1-based regimen for first-line treatment of advanced esophageal cancer in Japan. (2nd November 2022) Authors: Harada, Kentaro; Yamamoto, Shun; Kato, Ken Journal: Expert opinion on biological therapy Issue: Volume 22:Number 11(2022) Page Start: 1333 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
96. Phase I dose‐escalation trial of Sym004, an anti‐EGFR antibody mixture, in Japanese patients with advanced solid tumors. Issue 10 (25th September 2018) Authors: Kojima, Takashi; Yamazaki, Kentaro; Kato, Ken; Muro, Kei; Hara, Hiroki; Chin, Keisho; Goddemeier, Thomas; Kuffel, Stefan; Watanabe, Morihiro; Doi, Toshihiko Journal: Cancer science Issue: Volume 109:Issue 10(2018) Page Start: 3253 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
97. Phase I/II trial of 2‐weekly docetaxel combined with cisplatin plus fluorouracil in metastatic esophageal cancer (JCOG0807). Issue 9 (September 2014) Authors: Hironaka, Shuichi; Tsubosa, Yasuhiro; Mizusawa, Junki; Kii, Takayuki; Kato, Ken; Tsushima, Takahiro; Chin, Keisho; Tomori, Akihisa; Okuno, Tatsuya; Taniki, Toshikatsu; Ura, Takashi; Matsushita, Hisayuki; Kojima, Takashi; Doki, Yuichiro; Kusaba, Hitoshi; Fujitani, Kazumasa; Taira, Koichi; Seki, Sh... Journal: Cancer science Issue: Volume 105:Issue 9(2014:Sep.) Page Start: 1189 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
98. Phase I/II trial of chemoradiotherapy with concurrent S‐1 and cisplatin for clinical stage II/III esophageal carcinoma (JCOG 0604). Issue 10 (21st September 2015) Authors: Tahara, Makoto; Fuse, Nozomu; Mizusawa, Junki; Sato, Akihiro; Nihei, Keiji; Kanato, Keisuke; Kato, Ken; Yamazaki, Kentaro; Muro, Kei; Takaishi, Hiromasa; Boku, Narikazu; Ohtsu, Atsushi Journal: Cancer science Issue: Volume 106:Issue 10(2015:Oct.) Page Start: 1414 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
99. Phase II feasibility study of preoperative chemotherapy with docetaxel, cisplatin, and fluorouracil for esophageal squamous cell carcinoma. Issue 11 (18th October 2013) Authors: Hara, Hiroki; Tahara, Makoto; Daiko, Hiroyuki; Kato, Ken; Igaki, Hiroyasu; Kadowaki, Shigenori; Tanaka, Yoichi; Hamamoto, Yasuo; Matsushita, Hisayuki; Nagase, Michitaka; Hosoya, Yoshinori Journal: Cancer science Issue: Volume 104:Issue 11(2013:Nov.) Page Start: 1455 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
100. Phase II study of cetuximab with irinotecan for KRAS wild‐type colorectal cancer in Japanese patients. Issue 2 (6th August 2015) Authors: Terazawa, Tetsuji; Nishitani, Hitoshi; Kato, Ken; Hashimoto, Hironobu; Akiyoshi, Kohei; Ito, Yuriko; Nakamoto, Akihiro; Iwasa, Satoru; Nakajima, Takako Eguchi; Hamaguchi, Tetsuya; Yamada, Yasuhide; Shimada, Yasuhiro Journal: Asia-Pacific journal of clinical oncology Issue: Volume 13:Issue 2(2017) Page Start: e132 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗